HuikeshovenM., BeekJ.F., van der SlootJ.A.Twenty-five years of experimental research in transmyocardial revascularization: what have we learned?Ann Thorac Surg.2002; 74: 956–970.
2.
PetersonE.D., KaulP., KacmarekR.G.From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. J Am Coll Cardiol.2003; 42: 1611–1616.
3.
LiaoL., Sarria-SantameraA., MatcharD.B.Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization. Am J Cardiol.2005; 95: 1243–1245.
4.
BurnsS.M., BrownS., WhiteC.A.Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. Am J Cardiol.2001; 87: 861–867.
5.
CummingsJ.P., RatkoT.A., MatuszewskiK.A.Transmyocardial laser revascularization: a qualitative systematic review. Am J Manag Care.1998; 4: Spec No: SP152–66.
6.
MoherD., CookD.J., EastwoodS.Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet.1999; 354: 1896–1900.
7.
AldersonP., GreenS., HigginsJ.Cochrane Reviewers’ Handbook 4. 2.1, [updated December 2003]. Edition.Chichester, UK, John Wiley & Sons Ltd, 2004.
8.
AabergeL., NordstrandK., DragsundM.Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from the Norwegian randomized trial. J Am Coll Cardiol.2000; 35: 1170–1177.
9.
AllenK.B., DowlingR.D., FudgeT.L.Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med.1999; 341: 1029–1036.
10.
BurkhoffD., SchmidtS., SchulmanS.P.Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators: Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet.1999; 354: 885–890.
11.
FrazierO.H., MarchR.J., HorvathK.A.Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med.1999; 341: 1021–1028.
12.
SchofieldP.M., SharplesL.D., CaineNTransmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet.1999; 353: 519–524. Erratum in: Lancet. 1999; 353: 1714.
13.
van der SlootJ.A., HuikeshovenM., TukkieR.Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial. Ann Thorac Surg.2004; 78: 875–881.
14.
AabergeL., RootweltK., SmithH.J.Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methods. Scand Cardiovasc J.2001; 35: 8–13.
15.
AabergeL., AakhusS., NordstrandK.Myocardial performance after transmyocardial revascularization with CO(2) laser: a dobutamine stress echocardiographic study. Eur J Echocardiogr.2001; 2: 187–196.
16.
AabergeL., RootweltK., BlomhoffS.Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularization. J Am Coll Cardiol.2002; 39: 1588–1593.
17.
AllenK.B., DowlingR.D., AngellW.W.Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg.2004; 77: 1228–1234.
18.
MarchR.J.Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial. Semin Thorac Cardiovasc Surg.1999; 11: 12–18.
19.
MyersJ., OesterleS.N., JonesJ., BurkhoffD.Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. Am Heart J.2002; 143: 1052–1057.
20.
SpertusJ.A., JonesP.G., CoenM.Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial. Am J Med.2001; 111: 341–348.
21.
CampbellH.E., TaitS., BuxtonM.J.A UK trial-based cost–utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. Eur J Cardiothorac Surg.2001; 20: 312–318.
22.
HuikeshovenM., van der SlootJ.A., TukkieR.Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial. Lasers Surg Med.2003; 33: 1–7.
AllenK.B., DowlingR.D., SchuchD.R.Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized trial. Ann Thorac Surg.2004; 78: 458–465.
25.
FrazierO.H., TuzunE., EichstadtH.Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Tex Heart Inst J.2004; 31: 231–239.
26.
LoubaniM., ChinD., LevermentJ.N., GalinanesM.Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass. Ann Thorac Surg.2003; 76: 1163–1166.
27.
GuleserianK.J., ManiarH.S., CamilloC.J.Quality of life and survival after transmyocardial laser revascularization with the holmium: YAG laser. Ann Thorac Surg.2003; 75: 1842–1847; discussion 1847–1848.
28.
HorvathK.A., FergusonT.B.Jr., GuytonR.A., EdwardsF.H.Impact of unstable angina on outcomes of transmyocardial laser revascularization combined with coronary artery bypass grafting. Ann Thorac Surg.2005; 80: 2082–2085.
29.
LutterG., SaraiK., NitzscheE.Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function. Thorac Cardiovasc Surg.2000; 48: 79–85.
30.
JonesJ.W., SchmidtS.E., RichmanB.W.Holmium: YAG laser transmyocardial revascularization relieves angina and improves functional status. Ann Thorac Surg.1999; 67: 1596–1601.
31.
GalinanesM., LoubaniM., SenskyP.R.Efficacy of transmyocardial laser revascularization and thoracic sympathectomy for the treatment of refractory angina. Ann Thorac Surg.2004; 78: 122–128.
32.
LutterG., SaurbierB., NitzscheE.Transmyocardial laser revascularization (TMLR) in patients with unstable angina and low ejection fraction. Eur J Cardiothorac Surg.1998; 13: 21–26.
33.
OesterleS.N., SanbornT.A., AliN.Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial: potential class improvement from intramyocardial channels. Lancet.2000; 356: 1705–1710.
34.
LeonM.B., KornowskiR., DowneyW.E.A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol.2005; 46: 1812–1819.
35.
SalemM., RotevatnS., StavnesS.Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris. Am J Cardiol.2004; 93: 1086–1091.
36.
StoneG.W., TeirsteinP.S., RubensteinR.A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. Am Coll Cardiol.2002; 39: 1581–1587.
37.
BienenfeldL., FrishmanW., GlasserS.P.The placebo effect in cardiovascular disease. Am Heart J.1996; 132: 1207–1221.
38.
SaririanM., EisenbergM.J.Myocardial laser revascularization for the treatment of end-stage coronary artery disease. J Am Coll Cardiol.2003; 41: 173–183.
39.
DiegelerA., ChengD.Transmyocardial laser revascularization: a consensus statement of the International Society of Minimally Invasive Coronary Surgery (ISMICS) 2006. Innovations2006; 1: 314–322.
40.
BridgesC.R., HorvathK.A., NugentW.C.The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascularization. Ann Thorac Surg.2004; 77: 1494–1502.